Inspiration releases an important update about their clinical trial program for IB1001, an intravenous recombinant factor IX (rFIX) product that is being investigated for the treatment and prevention of bleeding episodes in people with hemophilia B. Click here for the official聽IBI press release.

Sign up for E-mails, Dateline Magazine, and other ways to stay connected.